SCHEMBL4183377

SCHEMBL4183377

Cc1cccc(CCNc2nc(-c3ccc(F)c(F)c3)ncc2N(C=O)Cc2ccncc2)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.35
GBA1 P04062 1/20 0.34
CYP1A2 P05177 6/20 0.33
CYP2C19 P33261 6/20 0.33
ALDH1A1 P00352 5/20 0.33
CYP3A4 P08684 5/20 0.33
HSD17B10 Q99714 4/20 0.33
HPGD P15428 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
CYP2D6 P10635 3/20 0.33
TSHR P16473 3/20 0.33
TDP1 Q9NUW8 3/20 0.33
JAK3 P52333 1/20 0.33
ALOX15 P16050 1/20 0.33
MAPK1 P28482 4/20 0.33
KDM4E B2RXH2 3/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 2/20 0.33
MAPT P10636 2/20 0.33
HIF1A Q16665 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4183066 0.93 CYP3A4 (0.39) POLBGBA1CYP1A2CYP2C19ALDH1A1
SCHEMBL4183367 0.89 CYP2C19 (0.37) POLBGBA1CYP1A2CYP2C19ALDH1A1
SCHEMBL4185956 0.85 POLB (0.35) POLBGBA1CYP1A2CYP2C19ALDH1A1
SCHEMBL4185582 0.85 GBA1 (0.39) GBA1CYP1A2ALDH1A1MAPK1LMNA
SCHEMBL4179058 0.82 GBA1 (0.40) GBA1CYP1A2ALDH1A1CYP3A4TDP1
SCHEMBL4184002 0.79 GBA1 (0.43) GBA1CYP1A2CYP3A4CYP2D6MAPT
SCHEMBL13743367 0.78 FLT3 (0.45) CYP1A2CYP2C19ALDH1A1SMN1; SMN2JAK3
SCHEMBL4178985 0.77 GBA1 (0.39) POLBGBA1CYP1A2ALDH1A1HSD17B10
SCHEMBL4183379 0.76 STAT6 (0.38) POLBGBA1CYP1A2CYP2C19ALDH1A1
SCHEMBL13743392 0.73 LMNA (0.44) POLBGBA1CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods CYTOKINETICS, INCORPORATED 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090198057-A1 Certain Chemical Entities, Compositions, and Methods MYLK, MYH2, MYH10 POLB 2180/4885GBA1 3801/4885CYP1A2 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.